Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.
about
Metabolic alterations and hepatitis C: From bench to bedsideRetinol-binding protein-4 expression marks the short-term mortality of critically ill patients with underlying liver disease: Lipid, but not glucose, mattersThe Evolving Interplay among Abundant Adipokines in Patients with Hepatitis C during Viral Clearance.Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and ImmunitySexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area.Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms.Link between plasminogen activator inhibitor-1 and cardiovascular risk in chronic hepatitis C after viral clearanceAssociation between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease.The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis.
P2860
Q26773261-9012740F-BAB0-4BB7-A398-EFFFCFA4542EQ33767554-C3B16C11-53ED-41E7-B253-1B72EB5EB2D4Q33851915-27273743-8E68-431E-B098-BEE7646C9495Q36199768-59DED1F1-5675-48B1-AFA3-693B016CD998Q36891841-A7F9D3A5-7B41-4E04-B7AB-D835F5769100Q37141091-6AF0C644-12BF-46C8-B3C8-9BC69171D1A7Q37638043-B9EC06D8-16F5-477A-B677-283D10EED2CDQ38808650-E5CD39F1-7C1C-4D62-9A08-7E05065831BCQ40305062-178F808B-E875-49EE-BD26-4B3CD7FC1B41Q45305677-80C7EEDD-8063-414F-A760-9CC17257A421
P2860
Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Plasminogen activator inhibito ...... ponectin vary between genders.
@en
Plasminogen activator inhibito ...... ponectin vary between genders.
@nl
type
label
Plasminogen activator inhibito ...... ponectin vary between genders.
@en
Plasminogen activator inhibito ...... ponectin vary between genders.
@nl
prefLabel
Plasminogen activator inhibito ...... ponectin vary between genders.
@en
Plasminogen activator inhibito ...... ponectin vary between genders.
@nl
P2093
P2860
P356
P1476
Plasminogen activator inhibito ...... ponectin vary between genders.
@en
P2093
Chau-Ting Yeh
Chen-Ming Hsu
Cheng-Tang Chiu
Jeng-Hwei Tseng
Ming-Ling Chang
Shu-Chun Chen
Shuen-Shian Shiau
Yung-Kuan Tsou
P2860
P304
P356
10.1111/JGH.12705
P577
2015-02-01T00:00:00Z